Curative intent therapy in oligometastatic lung cancer with an unresectable primary with N3 nodes: case report and review of the literature
{{output}}
Untreated NSCLC patients with brain metastases have a median survival of approximately 2 months; locally advanced stage III NSCLC patients treated with chemoradiation have a median survival of 16-19 months. Select patients with oligometastatic disease may have... ...
